InvestorsHub Logo
Followers 51
Posts 1681
Boards Moderated 0
Alias Born 02/15/2007

Re: BioBS2012 post# 108894

Tuesday, 01/22/2013 6:16:02 PM

Tuesday, January 22, 2013 6:16:02 PM

Post# of 345950
It is good for patients that it worked, but the 1.8 month increase in survival (27%) isn't that great.
Still, given the long list of failures in phase III trials for pancreatic cancer at least it is another
option for patients. When the data comes out I will add it to my tables on pancreatic cancer trials.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News